The effects of botulinum toxin A injection on the lateral pterygoid muscle in patients with a painful temporomandibular joint click: a randomized clinical trial study
Abstract:Background
Temporomandibular disorder (TMD) is the main cause of non-dental pain in orofacial area. The most common symptoms of TMD are joint pain, joint sound and limitation of jaw function. Botulinum toxin (BTX) injection is considered a potential treatment for TMD due to its pain-relieving properties and its ability to reduce muscle activity. Most of the studies are case series and further investigations are required to prove the efficacy of this treatment modality. Thus, in this study, we a… Show more
“…These results would agree with those obtained by Bakke et al [ 57 ], who, by BTX-A injections into the lateral pterygoid muscle, temporarily reduced the muscle action, but the clicking was permanently eliminated and did not reappear during the 1-year observation period, obtaining a small but clear positional improvement in the disc–condyle relationship. Similarly, other studies [ 58 , 59 , 60 ] with BTX-A injections into the lateral pterygoid muscle reported benefits on temporomandibular clicking.…”
Temporomandibular disorders are a common pathology affecting up to 70% of the population, with a maximum incidence in young patients. We used a sample of twenty patients recruited in the Maxillofacial Surgery Service of the University Hospital of Salamanca (Spain), who met the inclusion criteria, with unilateral painful symptomatology of more than three months’ duration. All patients were randomly treated by intramuscular and intra-articular injections of botulinum toxin (100 U) in eight predetermined points. Pain symptomatology was assessed by the visual analog scale (VAS) at the different locations, together with joint symptomatology, at baseline and six weeks after treatment. Adverse effects were also evaluated. In 85% of the patients, pain upon oral opening improved and 90% showed improvement in pain upon mastication. A total of 75% of the patients reported improvement in joint clicking/noise. Headaches improved or disappeared in 70% of the patients treated. Despite the limitations of the study and the preliminary results, intramuscular and intra-articular infiltrations with botulinum toxin were effective in the treatment of symptoms associated with temporomandibular disorders (TMDs), with minimal adverse effects.
“…These results would agree with those obtained by Bakke et al [ 57 ], who, by BTX-A injections into the lateral pterygoid muscle, temporarily reduced the muscle action, but the clicking was permanently eliminated and did not reappear during the 1-year observation period, obtaining a small but clear positional improvement in the disc–condyle relationship. Similarly, other studies [ 58 , 59 , 60 ] with BTX-A injections into the lateral pterygoid muscle reported benefits on temporomandibular clicking.…”
Temporomandibular disorders are a common pathology affecting up to 70% of the population, with a maximum incidence in young patients. We used a sample of twenty patients recruited in the Maxillofacial Surgery Service of the University Hospital of Salamanca (Spain), who met the inclusion criteria, with unilateral painful symptomatology of more than three months’ duration. All patients were randomly treated by intramuscular and intra-articular injections of botulinum toxin (100 U) in eight predetermined points. Pain symptomatology was assessed by the visual analog scale (VAS) at the different locations, together with joint symptomatology, at baseline and six weeks after treatment. Adverse effects were also evaluated. In 85% of the patients, pain upon oral opening improved and 90% showed improvement in pain upon mastication. A total of 75% of the patients reported improvement in joint clicking/noise. Headaches improved or disappeared in 70% of the patients treated. Despite the limitations of the study and the preliminary results, intramuscular and intra-articular infiltrations with botulinum toxin were effective in the treatment of symptoms associated with temporomandibular disorders (TMDs), with minimal adverse effects.
“…An extraoral preauricular in-plane approach with ultrasound guidance can minimize the risk of complications 4,9 . Lower injection volume and dose are essential to reduce the risk of hemorrhage and complications due to proximity to vital structures when injecting BTX into the LP muscle 10 . Patients should receive proper medication and follow instructions, such as chewing bilaterally, eating soft foods, and using warm packs to alleviate symptoms.…”
Botulinum toxin type-A (BTX-A) injections have emerged as a promising treatment for bruxism and temporomandibular joint (TMJ) disorders. However, there is a need for further exploration of optimal dosage, injection techniques, and intervals to maximize treatment effectiveness. Complications, such as velopharyngeal insufficiency, can occur after BTX-A injections, emphasizing the importance of precautionary measures. The utilization of ultrasound guidance and electromyography assistance can aid in precise injections and minimize the risk of complications. In addition, patients should receive appropriate medication and adhere to post-treatment instructions to alleviate symptoms. Follow-up procedures are essential to monitor potential complications, and in some cases, professional mental health care may be required. Further research is warranted to establish the safety and efficacy of BTX-A injections for the treatment of bruxism and TMJ disorders. This case study presents the development velopharyngeal insufficiency in a patient with chronic bruxism 3 days after receiving a BTX-A injection.
“…Joint click is mainly caused by DDWR and is a typical symptom for TMD [4]. ARS therapy is considered one of the most effective therapies for treating disc-displacement TMD.…”
Section: Discussionmentioning
confidence: 99%
“…Currently, the ultimate goal of TMD manegement is to reduce or eliminate pain, to improve jaw function, and to enhance the quality of life [2,3]. As generally agreed, conservative treatments should always be the rst choice for TMD, including health education, medication, rehabilitation therapy, occlusal splint therapy, and even arthroscopic surgery [4].…”
Background: Joint click is a typical symptom for TMD and can be treated by anterior repositioning splint (ARS) therapy. However, the effect of treatment in different age groups has not been evaluated. To analysis of the effectiveness of ARS therapy in the management of TMJ click in different age groups based on the results of clinical and CBCT examination. Methods: Patients with TMJ click admitted to TMJ Diagnosis and Treatment Center in 2021 were included in this study. They divided into 2 groups according to ages: ≤22Y and >22Y. Clinical features included click severity, symptom duration and CBCT imaging characteristics (condylar position and condylar ratio) were analyzed. Results: 169 patients with 338TMJs were studied in this study. The mean age of paitents was 18.78±2.8 in the ≤22Y group (78 patients) and 30.53±10.6 in the >22Y group (91 patients). Sex distribution, CSV, ratio of CSV=1, ratio of CSV=2, symptom duration showed no statistical differences between the two groups. Before ARS treatment, there was no significant difference in AJS, PJS and condylar ratio, but the proportion of posteriorly positioned condyle in ≤22Y group (72, 46.2%) was significantly smaller than that in the >22Y group (100, 54.9%). After ARS treatment, there was no statistically significant difference in AJS, PJS, condylar ratio and condylar position, but the change of condylar ratio in ≤22Y group (0.03±0.10) was significantly higher than that in >22Y group (-0.02±0.11). The positive results (39.7%) in ≤22Y group were greater than >22Y group (17.9%). The time required for CSV=0 in ≤22Y group (2.03±1.14) was significantly shorter than that in >22Y group (2.66±1.41). In the first and second months of follow-up, the ratio for CSV=0 (46.1%, 65.8%) in ≤22Y group was significantly higher than that in >22Y group (22.5%, 50.0%).Conclusions: ARS is more effective in joint clicking treatment in the group ≤22Y. Although AJS, PJS, condylar ratio and condylar position did not change significantly after ARS treatment, the rate of positive results in condylar position was higher in the ≤22Y group.Trial registration: This study was retrospectively registered On 28/03/2022 and endorsed by the Ethics committee (LCYJ2022014).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.